39 Papers
81 Citations
Yihao Wang is an academic researcher from Tianjin Medical University General Hospital. The author has contributed to research in topics: Bone marrow & Medicine. The author has an hindex of 10, co-authored 35 publications.
Chat about Author
Papers
Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma.
Jia Song,Qing Shao,Chun-Hong Li,Hui Liu,Jing Li,Yihao Wang,Wenjing Song,Lijuan Li,Guojin Wang,Zonghong Shao,Rong Fu +10 more
TL;DR: It is suggested that miR-21 affects apoptosis of lymphoma cells by regulating the expression of PTEN inDLBCL, which may be associated with increased poor prognosis for DLBCL patients and represents a useful approach for DL BCL treatment.
35
[Establishment and their biological characteristics of clonal cell subpopulations (NL9980 and L9981) from a human lung large cell carcinoma cell line (WCQH-9801)].
TL;DR: NL9980 and L9981 cell lines established from a human lung large cell carcinoma cell line have different biological and molecular characteristics.
25
Downregulation of Pim-2 induces cell cycle arrest in the G0/G1 phase via the p53-non-dependent p21 signaling pathway
Zhaoyun Liu,Hui Liu,Xin Yuan,Yihao Wang,Lijuan Li,Guojin Wang,Jia Song,Zonghong Shao,Rong Fu +8 more
TL;DR: Pim-2 may serve a role in hematopoietic tumors, lung cancer proliferation and cell cycle progression by regulating the p21 signaling pathway, and may be a potential therapy target in clinical cancer therapy.
Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes
Yanni Hua,Chaomeng Wang,Huijuan Jiang,Yihao Wang,Chunyan Liu,Lijuan Li,Hui Liu,Zonghong Shao,Rong Fu +8 more
TL;DR: Levels of intracellular iron, reactive oxygen species (ROS) and the expression of JNK and p38MAPK in NK cells and hematopoietic stem/progenitor cells (HSPCs) in MDS patients are examined to explore potential mechanisms by which iron overload promotes MDS progression.
17
[A randomized clinical trial of preoperative neoadjuvant chemotherapy followed by surgery in the treatment of stage III non-small cell lung cancer].
Qin Zhou,Lunxu Liu,Longyun Li,Guowei Che,Jin-Ji Yang,Yongfan Zhao,Jian Chen,Yihao Wang,Jianjun Qin,Mei Hou,Youling Gong,Lu W,Zhigang Li +12 more
TL;DR: The results demonstrate that the preoperative neoadjuvant chemotherapy is safe and effective to decrease the tumor staging, to increase the resection rate of the tumor, and to improve the long-term survival rate and life qualities of patients with stage III NSCLC.
16